参考文献/References:
[1]Schmid SL.Clathrin-coated vesicle formation and protein sorting: an integrated process[J].Annual Review of Biochemistry,1997(66):511-548.[2]Doray B,Kornfeld S.Gamma subunit of the AP-1 adaptor complex binds clathrin: implications for cooperative binding in coated vesicle assembly[J].Molecular Biology of the Cell,2001,12(7):1925-1935.[3]Ohno H,Tomemori T,Nakatsu F,et al.Mu1B,a novel adaptor medium chain expressed in polarized epithelial cells[J].FEBS Letters,1999,449(2-3):215-220.[4]Navarro Negredo P,Edgar JR,Wrobel AG,et al.Contribution of the clathrin adaptor AP-1 subunit μ1 to acidic cluster protein sorting[J].The Journal of Cell Biology,2017,216(9):2927-2943.[5]Tavares LA,da Silva EML,da Silva-Januário ME,et al.CD4 downregulation by the HIV-1 protein Nef reveals distinct roles for the γ1 and γ2 subunits of the AP-1 complex in protein trafficking[J].Journal of Cell Science,2017,130(2):429-443.[6]Weisz OA,Rodriguez-Boulan E.Apical trafficking in epithelial cells:signals,clusters and motors[J].Journal of Cell Science,2009,122(Pt 23):4253-4266.[7]刘宇,单本杰,沈国栋,等.AP1S1基因在乳腺癌中的表达与临床意义[J].安徽医科大学学报,2020,55(10):1535-1541.[8]Mallik S,Zhao Z.Towards integrated oncogenic marker recognition through mutual information-based statistically significant feature extraction:an association rule mining based study on cancer expression and methylation profiles[J].Quantitative Biology,2017,5(4):302-327.[9]Alshabi AM,Vastrad B,Shaikh IA,et al.Identification of Crucial Candidate Genes and Pathways in Glioblastoma Multiform by Bioinformatics Analysis[J].Biomolecules,2019,9(5):E201.[10]Hirst J,Robinson MS.Clathrin and adaptors[J].Biochimica Et Biophysica Acta,1998,1404(1-2):173-193.[11]Gámez-Pozo A,Trilla-Fuertes L,Prado-Vázquez G,et al.Prediction of adjuvant chemotherapy response in triple negative breast cancer with discovery and targeted proteomics[J].PLoS One,2017,12(6):e0178296.[12]Lehmann BD,Bauer JA,Chen X,et al.Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies[J].The Journal of Clinical Investigation,2011,121(7):2750-2767.[13]Rojas LK,Trilla-Fuertes L,Gámez-Pozo A,et al.Proteomics characterisation of central nervous system metastasis biomarkers in triple negative breast cancer[J].Ecancermedicalscience,2019(13):891.[14]Hagan CR,Lange CA.Molecular determinants of context-dependent progesterone receptor action in breast cancer[J].BMC Medicine,2014(12):32.[15]Davaadelger B,Murphy AR,Clare SE,et al.Mechanism of Telapristone Acetate (CDB4124) on Progesterone Receptor Action in Breast Cancer Cells[J].Endocrinology,2018,159(10):3581-3595.[16]ElSerag HB.Epidemiology of viral hepatitis and hepatocellular carcinoma[J].Gastroenterology,2012,142(6):1264-1273.e1.[17]Kou Y,Yan X,Liu Q,et al.HBV upregulates AP-1 complex subunit mu-1 expression via the JNK pathway to promote proliferation of liver cancer cells[J].Oncology Letters,2019,18(1):456-464.[18]Zheng BY,Gao WY,Huang XY,et al.HBx promotes the proliferative ability of HL-7702 cells via the COX-2/Wnt/β-catenin pathway[J].Molecular Medicine Reports,2018,17(6):8432-8438.[19]Miyoshi N,Wagatsuma H,Wakana S,et al.Identification of an imprinted gene,Meg3/Gtl2 and its human homologue MEG3,first mapped on mouse distal chromosome 12 and human chromosome 14q[J].Genes Cells,2000,5(3):211-220.[20]Sun Y,Cao FL,Qu LL,et al.MEG3 promotes liver cancer by activating PI3K/AKT pathway through regulating AP1G1[J].Eur Rev Med Pharmacol Sci,2019,23(4):1459-1467.[21]Huo L,Teng Z,Wang H,et al.A novel splice site mutation in AP1S2 gene for X-linked mental retardation in a Chinese pedigree and literature review[J].Brain and Behavior,2019,9(3):e01221.[22]Kumar V,Kumar V,McGuire T,et al.Challenges and Recent Advances in Medulloblastoma Therapy[J].Trends in Pharmacological Sciences,2017,38(12):1061-1084.[23]Qin C,Pan Y,Li Y,et al.Novel Molecular Hallmarks of Group 3 Medulloblastoma by Single-Cell Transcriptomics[J].Frontiers in Oncology,2021(11):622430.[24]Hase K,Nakatsu F,Ohmae M,et al.AP-1B-mediated protein sorting regulates polarity and proliferation of intestinal epithelial cells in mice[J].Gastroenterology,2013,145(3):625-635.[25]Vera-Badillo FE,Conde E,Duran I.Chromophobe renal cell carcinoma:a review of an uncommon entity[J].International Journal of Urology,2012,19(10):894-900.[26]Wu H,Fan L,Liu H,et al.Identification of Key Genes and Prognostic Analysis between Chromophobe Renal Cell Carcinoma and Renal Oncocytoma by Bioinformatic Analysis[J].Bio Med Research International,2020(2020):4030915.[27]Ostrowski SM,Fisher DE.Biology of Melanoma[J].Hematology/Oncology Clinics of North America,2021,35(1):29-56.[28]Trousil S,Chen S,Mu C,et al.Phenformin Enhances the Efficacy of ERK Inhibition in NF1-Mutant Melanoma[J].The Journal of Investigative Dermatology,2017,137(5):1135-1143.[29]Vitiello M,Tuccoli A,D’Aurizio R,et al.Context-dependent miR-204 and miR-211 affect the biological properties of amelanotic and melanotic melanoma cells[J].Oncotarget,2017,8(15):25395-25417.[30]Bogunovic D,O’Neill D W,Belitskaya-Levy I,et al.Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival[J].Proceedings of the National Academy of Sciences of the United States of America,2009,106(48):20429-20434.[31]Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA:A Cancer Journal for Clinicians,2018,68(6):394-424.[32]Chi J,Chung SY,Prasad S,et al.The Role of Olaparib in Metastatic Pancreatic Cancer[J].Cancer Medicine Journal,2021,4(3):89-91.[33]Sohal DPS,Kennedy EB,Cinar P,et al.Metastatic Pancreatic Cancer:ASCO Guideline Update[J].Journal of Clinical Oncology,2020:JCO2001364.[34]Slotwiński R,Lech G,Slotwińska SM.MicroRNAs in pancreatic cancer diagnosis and therapy[J].Central-European Journal of Immunology,2018,43(3):314-324.[35]Khalid M,Idichi T,Seki N,et al.Gene Regulation by Antitumor miR-204-5p in Pancreatic Ductal Adenocarcinoma:The Clinical Significance of Direct RACGAP1 Regulation[J].Cancers,2019,11(3):E327.[36]Yu D,Ruan X,Huang J,et al.Comprehensive Analysis of Competitive Endogenous RNAs Network,Being Associated With Esophageal Squamous Cell Carcinoma and Its Emerging Role in Head and Neck Squamous Cell Carcinoma[J].Frontiers in Oncology,2019(9):1474.[37]Schlessinger J.Ligand-induced,receptor-mediated dimerization and activation of EGF receptor[J].Cell,2002,110(6):669-672.[38]Tao X,Lu Y,Qiu S,et al.AP1G1 is involved in cetuximab-mediated downregulation of ASCT2-EGFR complex and sensitization of human head and neck squamous cell carcinoma cells to ROS-induced apoptosis[J].Cancer Letters,2017(408):33-42.